Search Results - "Молекулярная биология"

Source: Russian Journal of Pediatric Hematology and Oncology; Том 11, № 3 (2024); 46-59 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 11, № 3 (2024); 46-59 ; 2413-5496 ; 2311-1267

Subject Terms: диагностика, trilateral retinoblastoma, epidemiology, clinical data, molecular biology, diagnosis, трилатеральная ретинобластома, эпидемиология, клиническая картина, молекулярная биология

File Description: application/pdf

Relation: https://journal.nodgo.org/jour/article/view/1071/932; Bader J.L., Miller R.W., Meadows A.T., Zimmerman L.E., Champion L.A., Voute P.A. Trilateral retinoblastoma. Lancet. 1980;2(8194):582–3. doi:10.1016/s0140-6736(80)92009-7.; De Jong M.C., Kors W.A., De Graf P., Castelijns J.A., Kivela T., Moll A.C. Trilateral retinoblastoma: a systematic review and meta – analysis. Lancet Oncol. 2014;15(10):1157–67. doi:10.1016/S1470-2045(14)70336-5.; De Jong M.C., Shaikh F., Gallie B., Kors W.A., Jansen R.W., Dommering C., De Graf P., Moll A.C., Dimaras H., Shroﬀ M., Kivela T., Soliman S.E. Asynchronous pineoblastoma is more likely after early diagnosis of retinoblastoma: a meta-analysis. Acta Ophthalmol. 2022;100(1):e47–52. doi:10.1111/aos.14855.; Liu A.P.Y., Gudenas B., Lin T., Orr B.A., Klimo P. Jr, Rahul Kumar R., Bouﬀet E., Gururangan S., John R., Crawford J.R., Stewart J., Kellie S.J., Chintagumpala M., Fisher M.J., Daniel C., Bowers D.C., Hassall T., Indelicato D.J., Onar-Thomas A., David W., Ellison D.W., Frederick A., Boop F.A., Merchant T.E., Robinson G.W., Northcott P.A., Gajjar A. Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinic-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathol. 2019;139(2):259–71. doi:10.1007/s00401-019-02106-9.; Liu A.P.Y., Li B.K., Pfaﬀ E., Gudenas B., Vasiljevic A., Orr B.A., Dufour C., Snuderl M., Matthias A., Karajannis M.A., Rosenblum M.K., Hwang E.I., Ng H.-K., Jordan R., Hansford J.R., Szathmari A., Faure-Conter C., Merchant T.E., Levine M., Bouvier N., von Hoﬀ K., Martin Mynarek M., Rutkowski S., Sahm F., Kool M., Hawkins C., Onar-Thomas A., Robinson G.W., Gajjar A., Pfister S.M., Bouﬀet E., Northcott P.A., David T.W., Jones D.T.W., Huang A. Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study. Acta Neuropathol. 2021;141(5):771–85. doi:10.1007/s00401-021-02284-5.; Liu J., Ottaviani D., Sefta M., Desbrousses C., Chapeaublanc E., Aschero R., Sirab N., Lubieniecki F., Lamas G., Tonon L., Dehainault C., Hua C., Freneaux P., Reichman S., Karboul N., Biton A., Mirabal-Ortega L., Larcher M., Brulard C., Arrufat S., Nicolas A., Elarouci N., Popova T., Nemati F., Decaudin D., Gentien D., Baulande S., Mariani O., Dufour F., Guibert S., Vallot C., Lumbroso-Le Rouic L., Matet A., Desjardins L., Pascual-Pasto G., Sunol M., Catala-Mora J., Correa Llano G., Couturier J., Barillot E., Schaiquevich P., Gauthier-Villars M., Stoppa-Lyonnet D., Golmard L., Houdayer C., Brisse H., Bernard-Pierrot I., Letouze E., Viari A., Saule S., Sastre-Garau X., Doz F., Carcaboso A.M., Cassoux N., Pouponnot C., Goureau O., Chantada G., De Reynies A., Aerts I., Radvanyi F. A high-risk retinoblastoma subtype with stemness features, dediﬀerentiated cone states and neuronsal/ganglion cell gene expression. Nut Commun. 2021;12(1):55–78. doi:10.1038/s41467-021-25792-0.; Plaﬀ E., Aichmuller C., Sill M., Stichel D., Snuderl M., Karajannis M.A., Schuhmann M.U., Schittenhelm J., Hasselblatt M., Thomas C., Korshunov A., Rhizova M., Wittmann A., Kaufhold A., Iskar M., Ketteler P., Lohmann D., Orr B.A., Ellison D.W., Von Hoﬀ K., Mynarek M., Rutkowsky S., Sahm F., Von Deimling A., Jones D.T.W. Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations. Acta Neuropathol. 2019;139(2):243–57. doi:10.1007/s00401-019-02101-0.; Yamanaka R., Hayano A., Takashima Y. Trilateral retinoblastoma: a systematic review of 211 cases. Neurosurg Rev. 2019;42(1):39–48. doi:10.1007/s10143-017-0890-4.; Siegel D.A., King J.B., Lipo P.J., Durbin E.B., Tai E., Mills K., Van Dyne E., Lunsford N.B., Henley S.J., Wilson R.J. Counts, incidence rates, and trends of pediatric cancer in the United States, 2003–2019. JNCI. 2023;115(11):1337–54. doi:10.1093/jnci/djad115.; Greppin K., Cioﬃ G., Waite K.A., Ostrom Q.T., Landi D., Takaoka K., Kruchko C., Barnholtz-Sloan J.S. Epidemiology of pineoblastoma in the United States, 2000–2017. Neurooncol Pract. 2022;9(2):149–57. doi:10.1093/nop/npac009.; Zhang Y., Wang Y.-Z., Shi J.-T., Ma J.-M., Li B., Zhang W.-L., Gu H.-L., Zhou Y., Mei Y.-Y., Li S., Liu T.-T., Jiang L.B., Zhao H.-S., Ge X., Hu H.-M., Zhi T., Huang D.-S. Clinical analysis of 2790 children with retinoblastoma: a single-center experience in China. World J Pediatr. 2023;19(12):1169–80. doi:10.1007/s12519-023-00719-5.; Fang X., Wang Y., Yin J., Guo Y., Jia L., Zhang C., Jin M., Ni X., Zhao J. Clinical features and survival of Chinese children with trilateral retinoblastoma during 2006–2019: a retrospective multicenter study. Am J Ophthalmol. 2021;223:184–92. doi:10.1016/j.ajo.2020.10.002.; Gui T., Zheng H., Liu M., Xia Z., Ji X., Yin Q., Wang D., Li Y., Chen S. Clinical and magnetic resonance imaging features of 14 patients with trilateral retinoblastoma. Quant Imaging Med Surg. 2021;11(4):1458–69. doi:10.21037/qims-20-605.; Qureshi S., Francis J.H., Haque S.S., Dunkel I.J., Souweidane M.M., Friedman D.N., Abramson D.H. Magnetic resonance imaging screening for trilateral retinoblastoma: the Memorial Sloan Kettering Cancer Center experience 2006–2016. Ophthalmol Retina. 2020;4(3):327–35. doi:10.1016/j.oret.2019.10.010.; Li B.K., Vasiljevic A., Dufour C., Yao F., Ho B.L.B., Lu M., Hwang E.I., Gururangan S., Hansford J.R., Fouladi M., Nobusawa S., Laquerriere A., Delisle M-B., Fangusaro J., Forest B., Toledano H., Solano-Paez P., Leary S., Birks D., Hoﬀman L.M., Szathmari A., Faure-Conter C., Fan X., Catchpoole D., Zhou L., Schultz K.A.P., Ichimura K., Gauchotte G., Jabado N., Jones C., Loussouarn D., Mokhtary K., Rousseau A., Ziegler D.S., Tanaka S., Pomeroy S.L., Gajjar A., Ramaswamy V., Hawkins C., Grundy R.G., Hill D.A., Bouﬀet E., Huang A., Jouvet A. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study. Acta Neuropathol. 2019;139(2):223–41. doi:10.1007/s00401-019-02111-y.; Milman T., Grossniklaus H.E., Goldman-Lervy G., Kivela T.T., Coupland S.E., White V.A., Mudhar S.H., Eberhart C.G., Verdijk R.M., Heegaard S., Gill A.J., Jager M.J., Rodriguez-Reyers A.A., Esmaeli B., Hodge J.C., Cree I.A. The 5th edition of the World Health Organization of tumors of the eye and orbit. Ocul Oncol Pathol. 2023;9(3–4):71–95. doi:10.1159/000530730.; Louis D.N., Perry A., Wesseling P., Brat D.J., Cree I.A., Figarella-Branger D., Hawkins C., Ng N.K., Pfister S.M., Reifenberger G., Soﬃetti R., Von Deimling A., Ellison D.W. The 2021 WHO Classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231–51. doi:10.1093/neuonc/noab106.; Agarwal A., Bathla G., Soni N., Desai A., Ajmera P., Rao D., Gupta V., Vibhute P. Newly recognized genetic tumor syndromes of the CNS in the 5th WHO Classification: imaging overview with genetic updates. Am J Neuroradiol. 2024;45(2):128–38. doi:10.3174/ajnr.A8039.; Aschero A., Ganiewich D., Lamas G., Restrepo-Perdomo C.A., Ottaviani D., Zugbi S., Camarero S., Nespoli E., Vilanova M.C., Perez-Jaume S., Pascual-Pasto G., Sampor C., Grigorovski N., Salas B., Sunol M., Carcaboso A.M., Mora J., De Davila M.T.G., Doz F., Radvanyi F., Abramson D.H., Llera A.S., Schaiquevich P.S., Lubieniecki F., Chantada G.L. Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma. Pediatr Blood Cancer. 2023;71(1):e30717. doi:10.1002/pbc.30717.; Odemis D.A., Kebudi R., Bayramova J., Erciyas S.K., Turkcan G.K., Tuncer S.B., Erdogan O.S., Celik B., Gultaslar B.K., Bay S.B., Tuncer S., Yazici H. RB1 gene mutations and genetic spectrum in retinoblastoma cases. Medicine. 2023;102(36):e35068. doi:10.1097/MD.0000000000035068.; Cobbs L.V., Francis J.H., Dunkel I.J., Gobin Y.P., Brodie S.E., Abramson D.H. Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions. Pediatr Blood Cancer. 2021;68(5):e28845. doi:10.1002/pbc.28845.; Sweid A., Hammoud B., Weinberg J.H., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Ramesh S., Tjoumakaris S., Shields C.L., Ancona-Lezama D., Lim L.A.S., Dalvin L.A., Jabbour P. Intra-arterial chemotherapy for retinoblastoma in infants ≤ 10 kg: 74 treated eyes with 222 IAC sessions. Am J Neuroradiol. 2020;41(7):1286–92. doi:10.3174/ajnr.A6590.; Ketteler P., Hulsenbeck I., Frank M., Schmidt B., Jockel K.H., Lohmann D.R. The impact of RB1 genotype on incidence of second tumors in heritable retinoblastoma. Eur J Cancer. 2020;133:47–55. doi:10.1016/j.ejca.2020.04.005.; Alekseeva E.A., Babenko O.V., Kozlova V.M., Ushakova T.L., Kazubskaya T.P., Nemtsova M.V., Chesnocova G.G., Mikhaylenko D.S., Bure I.V., Kalinkin A.I., Kuznetsova E.B., Tanas A.S., Kutsev S.I., Zaletaev D.V., Strelnikov V.V. Parental origin of the RB1 gene mutations in families with low penetrance hereditary retinoblastoma. Cancers (Basel). 2021;13(20):5068. doi:10.3390/cancers13205068.; Rubens J.A., Erker C., Lindsay H., Ho B., Li B., Bouﬀet E., Cohen A., Eberhart C., Ertl-Wagner B., Mahajan A., Zacharoulis S., Huang A., Packer R. Infantile suprasellar tumor diagnosed as a pineoblastoma RB1 subgroup and treatment challenges: a pediatric SNO molecular tumor board. Neurooncol Adv. 2022;4(1):vdac092. doi:10.1093/noajnl/vdac092.; Vasiljevic A. Histopathology and molecular pathology of pediatric pineal parenchymal tumors. Childs Nerv Sist. 2022;39(9):2273–84. doi:10.1007/s00381-022-05637-x.; Ancona-Lezama D., Dalvin L.A., Shields C.L. Modern treatment of retinoblastoma: a 2020 review. Indian J Ophthalmol. 2020;68(11):2356–65. doi:10.4103/ijo.IJO_721_20.; Chevez-Barrioz P., Eagl R.C. Jr, Krailo M., Piao J., Albert D.M., Gao Y., Vemuganti G., Ali M.J., Khetan V., Honavar S.G., O’Brien J., Leahey A.-M., Matthay K., Meadows A., Chintagumpala M. Study of unilateral retinoblastoma with and without histopathologic high-risk features and the role of adjuvant chemotherapy: A Children’s Oncology Group study. J Clin Oncol. 2019;37(31):2883–91. doi:10.1200/JCO.18.01808.; Dittner-Moormann S., Reschke M., Abbink F.C.H., Aerts I., Atalay H.T., Bobrova N.F., Biewald E., Brecht I.B., Caspi S., Cassoux N., Castela G., Diarra Y., Duncan C., Ebinger M., Aldana D.G., Hadjistilianou D., Kepak T., Klett A., Kiratli H., Maka E., Opocher E., Pawinska-Wasikowska K., Rascon J., Russo I., Rutynowska-Pronicka O., Alvarez C.S., Pacheco S.S.R., Svojgr K., Timmermann B., Vishnevskia-Dai V., Eggert A., Ritter-Sovinz P., Bechrakiz N.E., Jenkinson H., Moll A., Munier F.L., Popovic M.B., Chantada G., Doz F., Ketteler P. Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG). Pediatr Blood Cancer. 2021;68(6):e28963. doi:10.1002/pbc.28963.; Friedman D.L., Krailo M., Villaluna D., Gombos D., Langholz B., Jubran R.F., Shields C., Murphree L., O’Brien J., Kessel S., Rodrigues-Galindo C., Chintagumpala M., Meadows A. Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children’s Oncology Group. Pediatr Blood Cancer. 2016;64(7):10.1002/pbc.26394. doi:10.1002/pbc.26394.; Jubran R.F., Villablanca J.G., Krailo M., Piao J., Huang L., Murphree O.L., O’Brien J., Gombos D., Shields C.L., Meadows A., Chintagumpala M. A single-arm study of systemic and sub-Tenon chemotherapy for Group C and D intraocular retinoblastoma: A Children’s Oncology Group study (ARET0231). Pediatr Blood Cancer. 2019;67(9):e28502. doi:10.1002/pbc.28502.; Liang T., Zhang X., Li J., Zhao P., Ji X. Intra-arterial chemotherapy as primary treatment for advanced unilateral retinoblastoma in China. Front Med. 2022;9:855661. doi:10.3389/fmed.2022.855661.; Dunkel I.J., Piao J., Chantada G.L., Banerjee A., Abouelnaga S., Buchsbaum J.C., Merchant T.E., Granger M.M., Jubran R.F., Weinstein J.L., Saguilig L., Abramson D.H., Krailo M.D., Rodriguez-Galindo C., Chintagumpala M.M. Intensive multimodality therapy for extraocular retinoblastoma: A Children’s Oncology Group trial (ARET0321). J Clin Oncol. 2022;40(33):3839–47. doi:10.1200/JCO.21.02337.; Hwang E.I., Kool M., Burger P.C., Capper D., Chavez L., Brabetz S., Williams-Hughes C., Billups C., Heier L., Jaju A., Michalski J., Li Y., Leary S., Zhou T., von Deimling A., Jones D.T.W., Fouladi M., Pollack I.F., Gajjar A., Packer R.J., Pfister S.M., Olson J.M. Extensive molecular and clinical heterogeneity in patients with histologically diagnosed CNS-PNET treated as a single entity: a report from the Children’s Oncology Group randomized ACNS0332 trial. J Clin Oncol. 2018;36(34):3388–95. doi:10.1200/JCO.2017.76.4720.; Jaju A., Hwang E.I., Kool M., Capper D., Clavez L., Brabetz S., Billuos C., Li Y., Fouladi M., Packer R.J., Pfister S.M., Olson J.M., Heier L.A. MRI features of histologically diagnosed supratentorial primitive neuroectodermal tumors and pineoblastomas in correlation with molecular diagnoses and out comes: a report from the Children’s Oncology Group ACNS0332 trial. Am J Neiroradiol. 2019;40(11):1796–803. doi:10.3174/ajnr.A625.; https://journal.nodgo.org/jour/article/view/1071

Availability: https://journal.nodgo.org/jour/article/view/1071
https://doi.org/10.21682/2311-1267-2024-11-3-46-59

View record from BASE

11

Academic Journal

MODERN IDEAS OF CELL DEATH MECHANISMS

Source: ВЕСТНИК ОБРАЗОВАНИЯ И РАЗВИТИЯ НАУКИ РОССИЙСКОЙ АКАДЕМИИ ЕСТЕСТВЕННЫХ НАУК. :15-27

Subject Terms: молекулярная биология, клеточная гибель, анастаз, апоптоз, некроз, цитопротекция, индукция гибели раковых клеток, 3. Good health

12

Academic Journal

Effect of low temperature on growth and development of wheat and response mechanism

Authors: Chen, Qiaoyan, Wie, Wenhui, Kandyba, Nataliya

Source: Plant Breeding and Seed Production; № 118 (2020); 149-153
Селекция и семеноводство; № 118 (2020); 149-153
Селекція і насінництво; № 118 (2020); 149-153

Subject Terms: 2. Zero hunger, 0106 biological sciences, 0301 basic medicine, 03 medical and health sciences, UDC 608.57.01.03, низька температура, морфологічний розвиток, фізіологічна, біохімічна та молекулярна біологія, low temperature, morphological development, рhysiological, biochemical and molecular biology, низкая температура, морфологическое развитие, физиологическая, биохимическая и молекулярная биология, 01 natural sciences

Access URL: http://journals.uran.ua/pbsd/article/download/222339/226625
http://skhid.kubg.edu.ua/index.php/0582-5075/article/view/222339
http://journals.uran.ua/pbsd/article/view/222339
http://journals.uran.ua/pbsd/article/download/222339/226625
http://journals.uran.ua/pbsd/article/view/222339

View record at OpenAIRE

13

Report

РОД MORBILLIVIRUS КАК ИСТОЧНИК ВОЗНИКНОВЕНИЯ КОРИ

Subject Terms: генетика вирусов, вирусы, RNA virus, Корь, клинические проявления кори, virus genetics, clinical manifestations of measles, молекулярная биология, парамиксовирус, paramyxovirus, Morbillivirus, molecular biology, РНК-вирус, viruses, Measles

14

Report

ВИРУС ПАПИЛЛОМЫ ЧЕЛОВЕКА: МЕХАНИЗМЫ ЗАРАЖЕНИЯ И ПУТИ ПЕРЕДАЧИ

Subject Terms: Инфекционные болезни, Human papillomavirus (HPV), Molecular biology, Вирус папилломы человека (ВПЧ), Бессимптомное носительство ВПЧ, Микробиология, Asymptomatic carrier of HPV, Вирусология, Infections, Microbiology, Инфекции, FOS: Biological sciences, Virology, Молекулярная биология, Infectious diseases, Биологические свойства ВПЧ, Biological properties of HPV

15

Academic Journal

Центральная догма молекулярной биологии и создание молекулярных компьютеров

Subject Terms: трансляция, молекулярная биология, молекулярные компьютеры, транскрипция, гены, экспрессия генов

File Description: application/pdf

Access URL: https://rep.vsu.by/handle/123456789/36895

16

Academic Journal

Влияние компонентов питательной среды на автолиз клеток и биосинтеза амилазы

Authors: Куликова, Н.Е., Чернобровина, А.Г., Роева, Н.Н., Максимова, В.В.

Subject Terms: 57 Биологические науки, 577 Материальные основы жизни. Биохимия. Молекулярная биология. Биофизика, 577.1 Химические основы жизни. Биохимия и биоорганическая химия. Общие вопросы, 577.15 Ферменты. Катализаторы биохимических реакций. Энзимология

File Description: application/pdf

Relation: https://eprints.tversu.ru/id/eprint/15039/1/%D0%91%D0%98%D0%9E%D0%9B%D0%9E%D0%93%D0%98%D0%AF_3_2025-95-106.pdf; Куликова, Н.Е. и Чернобровина, А.Г. и Роева, Н.Н. и Максимова, В.В. (2025) Влияние компонентов питательной среды на автолиз клеток и биосинтеза амилазы. Вестник ТвГУ. Серия: Биология и экология (3). С. 95-106. ISSN 1995-0160

Availability: https://eprints.tversu.ru/id/eprint/15039/
https://doi.org/10.26456/vtbio426

View record from BASE

17

Academic Journal